Results 211 to 220 of about 382,700 (243)

RNA-Based Therapies for Hypercholesterolemia and Coronary Artery Disease. [PDF]

open access: yesCureus
Lopez Mendoza MJ   +5 more
europepmc   +1 more source

Atopic dermatitis-messengers, second messengers and cytokines

Clinical and Experimental Dermatology, 1993
Atopic dermatitis (AD) shows many complex and interacting abnormalities of pharmacology, immunology and cellular control. Recent research in atopy has concentrated on abnormalities of cytokine production by T-helper cells. It is possible that cytokine imbalance causes many of the pharmacological and immunological changes seen in the disease.
openaire   +2 more sources

Atypical neural messengers

Trends in Neurosciences, 2001
Notions of what constitutes a neurotransmitter have changed markedly with the advent in the past decade of synaptic molecules, which satisfy key neurotransmitter criteria but differ radically from classical transmitters. Thus, NO and carbon monoxide are neither stored in synaptic vesicles nor released by exocytosis.
D E, Barañano, C D, Ferris, S H, Snyder
openaire   +2 more sources

Crosstalking second messengers

Nature Microbiology, 2020
By competing for the same binding site on SmbA, a regulatory nucleotide-binding protein, the bacterial second messengers c-di-GMP and (p)ppGpp inversely balance cell cycle re-entry of growth-arrested swarmer cells of Caulobacter crescentus.
openaire   +2 more sources

Metabolic Messengers: itaconate

Nature Metabolism
The metabolite itaconate has emerged as an important immunoregulator with roles in antibacterial defence, inhibition of inflammation and, more recently, as an inhibitory factor in obesity. Itaconate is one of the most upregulated metabolites in inflammatory macrophages.
A. F. McGettrick   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy